Intern, Biology

The candidate will help on various projects focused on delivery and design of siRNA therapeutics. As part of the RNAi Biology and Delivery Sciences team, the intern will work work closely in the lab with scientists from Biology, Chemistry, and in vivo groups. The intern will learn tissue processing, mammalian cell culture, and a variety of biochemical assays including ELISA, Western blotting, and qPCR.

This is a 10-12 week full-time assignment based on site in Cambridge, MA. The anticipated work term is May 20 - Aug 29, 2025.

Must have housing in the Boston area for the summer.

Learning Outcomes

1. Understand concepts and principles related to design and delivery of RNAi therapeutics

2. Gain expertise in a variety of biochemical assays/techniques (mammalian cell culture, qPCR, ELISA, Western blot, etc.)

3. Network and build understanding of biotech ecosystem

Qualifications

* Familiarity and some prior experience with mammalian cell culture, and basic biochemical assays (ELISA, qPCR, Western blot) would be needed.

* Willingness and enthusiasm to learn new techniques, build conceptual understanding of RNAi, and develop skills in experimental design and data analysis.

* Legal authorization to work in the U.S.

* At least 18 years of age prior to scheduled start date

About Alnylam:Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by "interfering" with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality.

Our culture:Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we've been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as the #1 Large Employer by Boston Globe Top Places to Work in 2023 for the third consecutive year, one of Science Magazine's Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK - among others.

At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients. Qualified applicants will receive consideration for employment without regard to their race, color, religion, age, sex, sexual orientation, gender identity or expression, national origin, ethnicity, marital status, protected veteran status, disability, or any other characteristics prohibited by law.